Baylor College of Medicine

Dyskeratosis Congenita Study (H-40548)

Description

Content

Radiation- and Alkylator-Free Hematopoietic Cell Transplantation for Bone Marrow Failure Due to Dyskeratosis Congenita / Telomere Disease

Age Requirement: 0-64

Dyskeratosis congenita is a disease that affects numerous parts of the body, most typically causing failure of the blood system. Lung disease, liver disease and cancer are other frequent causes of illness and death. Bone marrow transplantation (BMT) can cure the blood system but can make the lung and liver disease and risk of cancer worse because of DNA damaging agents such as alkylators and radiation that are typically used in the procedure. Based on the biology of DC, we hypothesize that it may be possible to avoid these DNA damaging agents in patients with DC, and still have a successful BMT. In this protocol we will test whether a regimen that avoids DNA alkylators and radiation can permit successful BMT without compromising survival in patients with DC.

NCT#/ClinicalTrials.gov ID: 01659606

More about this clinical trial

Contact

Helton Cruz

Phone 1: 832–824–1798

IRB: H-40548

Status:

Active

Created:

Back to topback-to-top